Home » Topics » BioWorld Science

BioWorld Science
RSS

Axis receives grant for plant-based vaccine development; phase I trials to begin in 1999

Dec. 1, 1997

Ibex announces changes in product development schedule

Dec. 1, 1997

Genetronics and Abbott enter drug supply alliance

Dec. 1, 1997

Ansan and Discovery Laboratories merge

Dec. 1, 1997

Genentech: Q3 1997 highlights

Dec. 1, 1997

Teva receives FDA approval for generic etodolac

Dec. 1, 1997

Cambridge NeuroScience: Q3 1997 highlights

Dec. 1, 1997

Company Profile: Coulter

Dec. 1, 1997

European approvals for RPR's Nasacort AQ

Nov. 28, 1997

Rituximab launched in Switzerland

Nov. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...